Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Oertel

Showing results (461-470 of 585) with videos related to

Pageof 59
Sort By:
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|August 8, 2009
Determination of hemispheric dominance with mental rotation using functional transcranial Doppler sonography and FMRIKatja Hattemer, Annika Plate, Johannes T Heverhagen, et al.
Neuro-Degenerative Diseases|June 5, 2010
Costs of Parkinson's disease and antiparkinsonian pharmacotherapy: an Italian cohort studyYaroslav Winter, Sonja von Campenhausen, Jens P Reese, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 8, 2016
Power calculations and placebo effect for future clinical trials in progressive supranuclear palsyMaria Stamelou, Jakob Schöpe, Stefan Wagenpfeil, et al.
JAMA Neurology|December 4, 2023
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson DiseaseShijun Yan, Cheng Jiang, Annette Janzen, et al.
Science Advances|November 12, 2020
Determinants of seeding and spreading of α-synuclein pathology in the brainMartin T Henrich, Fanni F Geibl, Harini Lakshminarasimhan, et al.
Health and Quality of Life Outcomes|March 19, 2013
Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's diseaseJudith Dams, Jens Klotsche, Bernhard Bornschein, et al.
Scientific Reports|September 15, 2017
Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cellsMatthias Höllerhage, Claudia Moebius, Johannes Melms, et al.
European Journal of Neurology|February 17, 2019
Abnormal α-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibilityV Donadio, K Doppler, A Incensi, et al.
Cell Death & Disease|November 16, 2019
Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neuronsGoutham K Ganjam, Kathrin Bolte, Lina A Matschke, et al.
European Journal of Endocrinology|November 4, 2011
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational StudyF Jakob, H Oertel, B Langdahl, et al.
Pageof 59

Showing results (461-470 of 585) with videos related to

Sort By:
Pageof 59
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|August 8, 2009
Determination of hemispheric dominance with mental rotation using functional transcranial Doppler sonography and FMRIKatja Hattemer, Annika Plate, Johannes T Heverhagen, et al.
Neuro-Degenerative Diseases|June 5, 2010
Costs of Parkinson's disease and antiparkinsonian pharmacotherapy: an Italian cohort studyYaroslav Winter, Sonja von Campenhausen, Jens P Reese, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 8, 2016
Power calculations and placebo effect for future clinical trials in progressive supranuclear palsyMaria Stamelou, Jakob Schöpe, Stefan Wagenpfeil, et al.
JAMA Neurology|December 4, 2023
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson DiseaseShijun Yan, Cheng Jiang, Annette Janzen, et al.
Science Advances|November 12, 2020
Determinants of seeding and spreading of α-synuclein pathology in the brainMartin T Henrich, Fanni F Geibl, Harini Lakshminarasimhan, et al.
Health and Quality of Life Outcomes|March 19, 2013
Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's diseaseJudith Dams, Jens Klotsche, Bernhard Bornschein, et al.
Scientific Reports|September 15, 2017
Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cellsMatthias Höllerhage, Claudia Moebius, Johannes Melms, et al.
European Journal of Neurology|February 17, 2019
Abnormal α-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibilityV Donadio, K Doppler, A Incensi, et al.
Cell Death & Disease|November 16, 2019
Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neuronsGoutham K Ganjam, Kathrin Bolte, Lina A Matschke, et al.
European Journal of Endocrinology|November 4, 2011
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational StudyF Jakob, H Oertel, B Langdahl, et al.
Pageof 59